Summary
Angiography in patients with unstable angina or myocardial infarction with subtotal coronary occlusion often reveals eccentric stenoses with irregular borders, suggesting ruptured atherosclerotic plaques and thrombosis, as documented by angioscopy and at autopsy. We have studied these processes in an ex vivo perfusion chamber, an in vivo swine model, and in human subjects. Our results, and those of other investigators, suggest that specific local risk factors at the time of plaque disruption influence the degree of thrombogenicity and, therefore, the various clinical syndromes. These risk factors can be divided into 2 groups: local vessel wall-related factors, and local (focal action) systemic factors. These risk factors include the following: 1) Rheological factors. It has been demonstrated that the more severe the stenotic lesion after plaque rupture, the higher the local shear rate with enhanced platelet deposition and thrombus formation; platelet deposition and thrombosis are particularly likely if the rupture includes the apex of the stenotic plaque, because of the high shear rate induced. 2) Degree of plaque damage. Plaque rupture produces a rough surface and stimulates an occlusive thrombus, which is enhanced depending on the degree of damage or amount of collagen type I and macrophage-dependent tissue factor exposed. 3) Residual thrombus. After spontaneous or pharmacological reperfusion, the surface of the residual thrombus is very thrombogenic and may contribute to reocclusion; this is partially due to thrombin bound to fibrin in the original thrombus. 4) Systemic factors. There is clinical and experimental evidence to suggest that 3 systemic factors at the time of plaque rupture may enhance thrombogenicity. Firstly, the levels of epinephrine (adrenaline) [i.e. in stress, smoking, early acute myocardial infarction], secondly, the level of serum cholesterol, and thirdly, impaired fibrinolysis resulting from high serum lipoprotein(a).
Similar content being viewed by others
References
Ambrose JA, Tannenbaum MA, Alexopoulus D, Fuster V. Angiographic progression of coronary artery disease and the development of myocardial infarction. Journal of the American College of Cardiology 12: 56–62, 1988
Ambrose JA, Winters SL, Stern A, Fuster V. Angiographic morphology and the pathogenesis of unstable angina pectoris. Journal of the American College of Cardiology 5: 609–616, 1985
Ardlie NG, McGuiness JA, Garrett JJ. Effect on human platelets of catecholamines at levels achieved at the circulation. Atherosclerosis 58: 251–259, 1985
Armstrong VW, Cremer P, Eberle E, Manke A, Shulze F, et al. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis dependence on serum LDL levels. Atherosclerosis 62: 249–257, 1986
Ashton JH, Benedict CR, Fitzgerald C. Serotonine as a mediator of cyclic flow variations in stenosed canine coronary arteries. Circulation 73: 572–578, 1986a
Ashton JH, Schmitz JM, Campbell WB. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists. Circulation Research 59: 568–578, 1986b
Badimon JJ, Badimon L, Turitto VT, Fuster V. Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels. In vivo study in the rabbit model. Arteriosclerosis 11: 395–402, 1991
Badimon L, Badimon JJ. Mechanisms of arterial thrombosis in non-parallel streamlines. Platelet thrombi grow on the apex of stenotic severely injured vessel wall. Journal of Clinical Investigation 84: 1134–1144, 1989
Badimon L, Badimon JJ, Galvez A, Chesebro JH, Fuster V. Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model. Arteriosclerosis 6: 312–320, 1986
Badimon L, Badimon JJ, Lasilla R, Heras M, Chesebro JH, et al. Thrombin inhibition by hirudin decreases platelet thrombus growth on areas of severe vessel wall injury. Journal of the American College of Cardiology 13: 145A, 1989
Badimon L, Badimon JJ, Lassila R, Heras M, Chesebro JH, et al. Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I or arterial flow condition in a porcine model: effects of hirudins, heparin and calcium chelation. Blood 78: 423–434, 1991a
Badimon L, Badimon JJ, Lassila R, Merino A, Chesebro JH, et al. Re-thrombosis on an evolving thrombus is mediated by thrombus-bound thrombin that is not inhibited by systemic heparin. Thrombosis and Haemostasis 65: 760, 321, 1991b
Badimon L, Badimon JJ, Turitto VT, Vallabhajosula S, Fuster V. Platelet thrombus formation on collagen type I. Influence of blood rheology, von Willebrand factor and blood coagulation. Circulation 78: 1431–1442, 1988a
Badimon L, Lassila R, Badimon JJ, Fuster V. An acute surge of epinephrine stimulates platelet deposition to severely damaged vascular wall. Journal of the American College of Cardiology 15: 181A, 1991c
Badimon L, Lassila R, Badimon JJ, Vallabhajosula S, Chesebro JH, et al. Residual thrombus is more thrombogenic than severely damaged vessel wall. Circulation 78: 119, 474, 1988b
Badimon L, Turitto VT, Rosemark JA, Badimon JJ, Fuster V. Characterization of a tubular flow chamber for studying platelet interaction with biological and prosthetic materials. Deposition of 111ndium-labelled platelets on collagen, subendothelium, and Goretex (R). Journal of Laboratory and Clinical Medicine 110: 706–718, 1987
Barbash GI, Hanoch H, Roth A, Miller HI, Rath S, et al. Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction. American Journal of Cardiology 64: 1231–1235, 1989
Brown GB, Gallery CA, Badger RS, Kennedy JW, Mathey D, et al. Incomplete lysis of thrombus in the moderated underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: quantitative angiographic observation. Circulation 73: 653–661, 1986
Capone G, Wolf NM, Meyers B, Meister SG. Frequency of intracoronary filling defects by angiography in unstable angina pectoris at rest. American Journal of Cardiology 56: 403–406, 1985
Carvalho ACA, Colman RW, Lees RS. Platelet function in hyperlipoproteinemia. New England Journal of Medicine 290: 434–438, 1974
Cohen RA, Shepherd JT, Vanhoutte PM. Inhibitory role of endothelium in the response of isolated coronary arteries to platelets. Science 221: 273–274, 1983
Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, et al. Association of levels of lipoprotein(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 74: 758–765, 1986
Davies MJ, Thomas AC. Plaque fissuring. The cause of acute myocardial infarction, sudden ischemic death and crescendo angina. British Heart Journal 53: 363–373, 1985
Davies SW, Marchant B, Lyon JP, Timmis AD, Rothman MT, et al. Coronary lesion morphology in acute myocardial infarction: demonstration of early remodeling after streptokinase treatment. Journal of the American College of Cardiology 16: 1079–1086, 1990
Edelberg JM, Gonzalez-Grnow M, Pizzo SV. Lipoprotein(a) inhibits streptokinase-mediated activation of human plasminogen. Biochemistry 72: 374A, 1989
Falk E. Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. American Journal of Cardiology 63: 1114E–1120E, 1989
Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 229: 373–376, 1980
Fuster V, Chesebro JH. Mechanisms of unstable angina. New England Journal of Medicine 315: 1023–1025, 1986
Fuster V, Chesebro JH, Frye RL. Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy. Circulation 63: 546–551, 1981
Fuster V, Stein B, Badimon L, Badimon JJ, Ambrose JA, et al. Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation 82: II47–II59, 1990
Gotoh K, Minamino T, Hatoh O, Hamano Y, Fukui S, et al. The role of intracoronary thrombus in unstable angina: angiographic assessment and thrombolytic therapy during ongoing anginal attacks. Circulation 77: 526–534, 1988
Gulba DC, Bartheis M, Westhoff-Bleck M, Jost S, Raffienbeul W, et al. Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy. Circulation 83: 937–944, 1991
Hackett D, Davies G, Chierchia S. Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilatory therapy. New England Journal of Medicine 317: 1055–1059, 1987
Hajjar KA, Gavish D, Breslow JL, Nachman RL. Lipoprotein(a) modulation of endothelial surface fibrinolysis and its potential role in atherosclerosis. Nature 339: 303–305, 1989
Harpel PL, Gordon BR, Parker TS. Plasmin catalyzes binding of lipoprotein(a) to immobilized fibrinogen and fibrin. Proceedings of the National Academy of Sciences USA 56: 3847–3851, 1989
Houston DS, Shepherd JT, Vanhoutte PM. Aggregating human platelets caused direct contraction and endothelium-dependent relaxation of isolated canine coronary arteries. Role of serotonin, thromboxane A2 and adenine nucleotides. Journal of Clinical Investigation 78: 539–544, 1986
Hunt BJ. The relation between abnormal hemostatic function and the progression of coronary disease. Current Opinion in Cardiology 5: 758–765, 1990
Ip JH, Fuster V, Badimon L, Badimon JJ, Taubman MB, et al. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. Journal of the American College of Cardiology 15: 1667–1687, 1990
Komuro I, Kurihara H, Sugiyama T. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Letters 238: 249–252, 1988
Lam JYT, Chesebro JH, Steele PM, Badimon L, Fuster V. Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. Circulation 75: 243–248, 1987
Lassila R, Badimon JJ, Vallabhajosulan S, Badimon L. Dynamic monitoring of platelet deposition on severely damaged vessel wall in flowing blood. Effects of different stenosis on thrombus growth. Arteriosclerosis 10: 306–315, 1990
Lassila R, Seyberth HW, Haapanen A, Schweer H, Koskenvuo M, et al. Vasoactive and atherogenic effects of cigarette smoking — a study of monozygotic twins discordant for smoking. British Medical Journal 297: 955–957, 1988
Little WC, Constantinescu M, Applegate RJ. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 78: 1156–1166, 1988
Loscalzo J. Lipoprotein(a): a unique risk factor for atherothrombotic disease. Arteriosclerosis 10: 672–679, 1990
Luscher TF. Endothelium-derived relaxing and contracting factors: potential role in coronary artery disease. European Heart Journal 10: 847–857, 1989
Mandelkorn JB, Wolf NM, Singh S, Schechter JA, Kersh RI, et al. Intracoronary thrombus in nontransmural myocardial infarction and in unstable angina pectoris. American Journal of Cardiology 52: 1–6, 1983
Maseri A, Labbate A, Barodi G. Coronary vasospasm as a possible cause of myocardial infarction: a conclusion derived from the study of ‘preinfarction’ angina. New England Journal of Medicine 299: 1271–1277, 1978
McLean JW, Tomlinson JE, Kuang WJ. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 30: 132–137, 1987
McLenachan JM, Vita J, Fish RD, Treasure CB, Cox DA, et al. Early evidence of endothelial vasodilator dysfunction at coronary branch points. Circulation 82: 1169–1173, 1990
Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. A potential basis for the thrombotic risk associated with lipoprotein(a). Nature 339: 301–303, 1989
Milner P, Bodin P, Loesch A, Burnstock G. Rapid release of endothelin and ATP from isolated aortic endothelial cells exposed to increased flow. Biochemical and Biophysical Research Communications 170: 649–656, 1990
Moncada S, Gryglewsky R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663–665, 1976
Muller JE, Stone PH, Turi ZQ, Rutherford JD, et al. and the MILIS Study Group. Circadian variation in the frequency of onset of acute myocardial infarction. New England Journal of Medicine 313: 1315–1322, 1985
Muller JE, Toefler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 79: 733–743, 1989
Nadeau RA, de Champlain J. Plasma catecholamines in acute myocardial infarction. American Heart Journal 98: 548–554, 1979
Olofsson BO, Dahlen G, Nilsson TK. Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. European Heart Journal 10: 77–82, 1989
Oseroff A, Krishnamurti C, Hasset A, Tang D, Alving B. Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease. Journal of Laboratory and Clinical Medicine 113: 88–93, 1990
Paramo JA, Colucci M, Collen D. Plasminogen activator inhibitor in blood of patients with coronary artery disease. British Medical Journal 291: 573–574, 1985
Penny WJ, Chesebro JH, Heras M, Badimon L, Fuster V. In vivo identification of normal and damaged endothelium by quantitative coronary angiography and infusion of acetylcholine and bradykinin in pigs. Journal of the American College of Cardiology 11: 29A, 1988
Rentrop KP, Feit F, Blanke H, Sherman W, Thornton JC. Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Circulation 80: 1166–1175, 1989
Seed M, Hoppichler F, Reaveley D, McCarthy S, Thompson GR, et al. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to CHD patients with familial hypercholesterolemia. New England Journal of Medicine 322: 1494–1499, 1990
Sherman CT, Litvak F, Grundfest W. Coronary angioscopy in patients with unstable angina. New England Journal of Medicine 315: 913–919, 1986
Stuart MJ, Gerrard JM, White JG. Effect of cholesterol on production of thromboxane B2 by platelets in vitro. New England Journal of Medicine 302: 6–10, 1980
Sumpio BE, Widmann MD. Enhanced production of an endothelium-derived contracting factor by endothelial cells subjected to pulsatile stretch. Surgery 108: 277–282, 1990
Tabuchi Y, Nakamaru M, Rakugi H, Nagano M, Ogihara T. Endothelin enhances adrenergic vasoconstriction in perfused rat mesenteric arteries. Biochemical and Biophysical Research Communications 159: 1304–1308, 1989
Toyo-oka T, Aizawa T, Suzuki N, Hirata Y, Miyauchi T, et al. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 83: 476–483, 1991
Van de Werf F, Arnold AER, and the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator (r-tPA). Effect of intravenous tissue plasminogen activator on infarct size, left ventricular function and survival in patients with acute myocardial infarction. British Medical Journal 297: 374–379, 1988
Vanhoutte PM, Shimokawa H. Endothelium-derived relaxing factor and coronary vasospasm. Circulation 80: 1–9, 1989
Webster MWI, Chesebro JH, Mruk JS, Grill DE, Badimon JJ, et al. Hypercholesterolemia induces abnormal coronary vaso-motion in vivo. Journal of the American College of Cardiology 17: 173A, 1991
Weitz JI, Hudoba M, Massel D, Maragamore J, Hirsh J. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. Journal of Clinical Investigation 86: 385–391, 1990
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415, 1988
Yang Z, Richard D, von Segesser L, Bauer E, Stulz P, et al. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries: a new mechanism of vasospasm? Circulation 82: 188–195, 1990
Zarins CK, Giddens DP, Bharadvaj BK. Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear rate. Circulation Research 53: 502–514, 1983
Zeiher AM, Drexel H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83: 391–401, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Badimon, L., Badimon, J.J., Cohen, M. et al. Vessel Wall-Related Risk Factors in Acute Vascular Events. Drugs 42 (Suppl 5), 1–9 (1991). https://doi.org/10.2165/00003495-199100425-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199100425-00003